Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.72%28.73B | 2.52%31.82B | 1.85%7.74B | 6.95%8.66B | -0.10%7.58B | 1.12%7.85B | 13.47%31.04B | 27.91%7.6B | 8.08%8.1B | 6.21%7.59B |
| Cost of revenue | -11.62%24.88B | 4.77%28.15B | 5.63%6.95B | 8.69%7.63B | 6.49%6.62B | -1.44%6.96B | 6.54%26.87B | 15.39%6.58B | 1.59%7.02B | -1.83%6.22B |
| Gross profit | 4.82%3.85B | -11.97%3.67B | -22.50%791.1M | -4.37%1.03B | -29.96%960.19M | 26.85%889.94M | 95.31%4.17B | 324.97%1.02B | 85.29%1.08B | 68.87%1.37B |
| Operating expense | 1.19%3.18B | 0.41%3.14B | -2.82%785.73M | 5.06%785.61M | 3.12%780.87M | -3.17%790.59M | 8.01%3.13B | 15.26%808.56M | 0.97%747.75M | 10.26%757.25M |
| Operating profit | 26.42%668.15M | -49.20%528.52M | -97.47%5.37M | -25.78%244.48M | -70.78%179.32M | 186.46%99.35M | 236.43%1.04B | 146.02%212.28M | 306.89%329.4M | 390.83%613.62M |
| Net non-operating interest income (expenses) | 26.04%46.99M | -4.96%37.28M | -71.98%2.55M | -7.66%14.21M | -66.73%-2.58M | 41.75%23.11M | 19.79%39.23M | 1,415.05%9.09M | 3.67%15.38M | 44.18%-1.55M |
| Non-operating interest income | 23.77%69.23M | -2.47%55.94M | -44.34%7.61M | -3.97%19.24M | -43.76%1.83M | 33.65%27.26M | 27.40%57.36M | 490.07%13.67M | 12.46%20.03M | 878.68%3.26M |
| Non-operating interest expense | 19.22%22.24M | 2.91%18.66M | 10.50%5.06M | 8.23%5.03M | -8.22%4.41M | 1.42%4.16M | 47.72%18.13M | 52.28%4.58M | 56.28%4.65M | 54.92%4.8M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -95.99%1.2M | 575.36%30M | 0 | 0 | 0 | 30M | -40.24%-6.31M | -6.31M | 0 | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 65.26%-7.88M | -129.23%-22.68M | 84.42%-1.85M | -296.81%-11.11M | -1,159.78%-1.9M | -102.91%-7.82M | 43.38%-9.89M | -669.26%-11.86M | 179.01%5.65M | -99.60%179K |
| Less:Other special charges | -86.60%2.35M | 140.01%17.5M | -61.64%4.55M | 248.95%8.41M | 1,159.78%1.9M | 111.02%2.64M | 211.31%7.29M | 171.75%11.86M | -124.73%-5.65M | 98.69%-179K |
| Less:Write off | 6.84%5.53M | 99.00%5.18M | ---2.7M | --2.7M | --0 | 99.00%5.18M | -89.17%2.6M | --0 | --0 | --0 |
| Other non-operating income (expenses) | -27.63%64.28M | 68.01%88.83M | 127.00%30.41M | 81.30%21.31M | -6.80%11.37M | 65.82%25.73M | 1,697.76%52.87M | 143.98%13.4M | 21.25%11.76M | 38.37%12.2M |
| Income before tax | 16.74%772.75M | -40.70%661.95M | -83.15%36.49M | -25.76%268.88M | -70.18%186.21M | 295.95%170.37M | 247.83%1.12B | 143.45%216.6M | 355.37%362.18M | 254.82%624.45M |
| Income tax | 3.36%200.58M | 85.79%194.05M | 84.18%-19.83M | -43.06%74.43M | -34.09%73.1M | 660.58%66.35M | -50.87%104.45M | -145.66%-125.35M | 404.11%130.73M | 111.03%110.91M |
| Net income | 22.28%572.17M | -53.76%467.9M | -83.53%56.32M | -15.99%194.45M | -77.97%113.11M | 238.48%104.02M | 204.56%1.01B | 144.24%341.94M | 334.17%231.45M | 316.05%513.54M |
| Net income continuous operations | 22.29%572.17M | -53.76%467.9M | -83.53%56.31M | -15.99%194.45M | -77.97%113.11M | 238.49%104.02M | 204.56%1.01B | 144.24%341.94M | 334.17%231.45M | 316.05%513.54M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 22.28%572.17M | -53.76%467.9M | -83.53%56.32M | -15.99%194.45M | -77.97%113.11M | 238.48%104.02M | 204.56%1.01B | 144.24%341.94M | 334.17%231.45M | 316.05%513.54M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 22.28%572.17M | -53.76%467.9M | -83.53%56.32M | -15.99%194.45M | -77.97%113.11M | 238.48%104.02M | 204.56%1.01B | 144.24%341.94M | 334.17%231.45M | 316.05%513.54M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 22.17%148.61 | -53.82%121.64 | -83.57%14.62 | -16.07%50.55 | -78.01%29.4 | 238.39%27.07 | 204.50%263.39 | 144.21%89 | 333.99%60.23 | 315.80%133.72 |
| Diluted earnings per share | 22.17%148.61 | -53.82%121.64 | -83.57%14.62 | -16.11%50.5274 | -78.01%29.4 | 238.39%27.07 | 204.50%263.39 | 144.20%88.9843 | 333.76%60.23 | 315.80%133.72 |
| Dividend per share | 28.57%45 | -58.82%35 | -90.91%5 | 0 | 0.00%30 | 0 | 1,316.67%85 | 5,400.00%55 | 0 | 500.00%30 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |